1. Home
  2. AAPG vs FORTY Comparison

AAPG vs FORTY Comparison

Compare AAPG & FORTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$27.68

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

FORTY

Formula Systems (1985) Ltd.

HOLD

Current Price

$190.56

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAPG
FORTY
Founded
2009
1985
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
2025
1997

Fundamental Metrics

Financial Performance
Metric
AAPG
FORTY
Price
$27.68
$190.56
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$48.50
N/A
AVG Volume (30 Days)
4.1K
617.0
Earning Date
03-26-2026
11-20-2025
Dividend Yield
N/A
0.91%
EPS Growth
N/A
N/A
EPS
N/A
4.53
Revenue
$54,524,554.00
$3,016,039,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$368.64
N/A
P/E Ratio
N/A
$36.08
Revenue Growth
N/A
11.45
52 Week Low
$16.50
$80.15
52 Week High
$48.45
$190.56

Technical Indicators

Market Signals
Indicator
AAPG
FORTY
Relative Strength Index (RSI) 38.05 72.60
Support Level $25.83 $170.00
Resistance Level $29.37 $184.16
Average True Range (ATR) 0.91 2.74
MACD -0.18 3.33
Stochastic Oscillator 16.46 100.00

Price Performance

Historical Comparison
AAPG
FORTY

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.

Share on Social Networks: